Why do some patients with MCI or Alzheimer’s improve while others decline? Learn how root causes, genetics, neuroplasticity, and protocol compliance affect outcomes.
Heavy metals and environmental toxins may contribute to brain fog, memory loss, Mild Cognitive Impairment, and Alzheimer's disease. Learn how Precision Medicine investigates toxic exposures and supports brain health.
Mold exposure may contribute to brain fog, memory loss, Mild Cognitive Impairment, and Alzheimer's disease. Learn how mold-related inflammation and toxins may affect brain health and why a Precision Medicine approach matters.
Sleep apnea is a surprisingly common cause of memory loss, brain fog, Mild Cognitive Impairment, and Alzheimer's disease. Learn why sleep matters and how the Carroll Cognitive Method™ addresses root causes.
Is Alzheimer’s disease related to insulin resistance? Yes, it may play a significant role in memory loss and cognitive decline. Researchers have even coined the term “Type 3 diabetes” to describe the connection between impaired brain metabolism and Alzheimer’s. The brain requires vast amounts of energy, and insulin resistance can hinder its ability to utilize that energy effectively. This shift in understanding emphasizes the importance of metabolic health in cognitive function. If you or a loved one is experiencing cognitive decline, exploring the relationship between blood sugar and brain health could open new avenues for support and improvement.
Chronic inflammation may be one of the biggest drivers of memory loss, Mild Cognitive Impairment, and Alzheimer's disease. Learn why inflammation matters and how a Precision Medicine approach addresses root causes.
Is Alzheimer’s disease simply a drug deficiency, or does it reflect a systems breakdown in the brain? For decades, research focused on finding a single molecule to target, but results have fallen short. At The Carroll Institute, we believe that understanding the interconnected systems of metabolism, inflammation, sleep, and more is crucial. When multiple systems struggle, cognitive decline can occur. This comprehensive approach offers hope for patients and families, revealing that there may be many opportunities for intervention. Discover how a systems-based evaluation can change the conversation around Alzheimer’s disease and cognitive health.
Drugs like lecanemab and donanemab successfully remove amyloid from the brain, yet they do not restore lost memory or reverse Alzheimer's disease. Patients generally continue to decline, although at a somewhat slower rate. That raises an important question: If amyloid is truly the primary cause of Alzheimer's disease, why doesn't removing it produce dramatically greater improvement? At the Carroll Institute, we believe amyloid may be part of the story, but not the whole story. The brain is influenced by inflammation, metabolism, sleep, hormones, toxins, vascular health, and neural network function.
